Neil Mathews
Stevenage Bioscience Catalyst(GB)
Publications by Year
Research Areas
Cyclopropane Reaction Mechanisms, Synthesis and Catalytic Reactions, Synthesis and Biological Evaluation, Asymmetric Synthesis and Catalysis, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors(2004)219 cited
- → Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor(2006)102 cited
- → A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein(2019)85 cited
- → State of the Art in Respiratory Syncytial Virus Drug Discovery and Development(2018)74 cited
- → Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion(2021)68 cited
- → Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors(2004)46 cited
- → Synthesis and Serotonergic Activity of Substituted 2,N-Benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N,N-dimethyltrypt- amine Derivatives: Novel Antagonists for the Vascular 5-HT1B-like Receptor(1999)43 cited
- → A Novel Series of 2,5-Substituted Tryptamine Derivatives as Vascular 5HT1B/1D Receptor Antagonists(1997)34 cited
- → Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors(2009)22 cited
- → Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach(2009)21 cited